Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-13 Sale |
2025-02-14 5:54 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO |
91,817 | $7.9222 | $727,390 | 191,516 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-07 Option Award |
2025-02-10 5:37 pm |
N/A 2035-02-06 |
ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO |
337,500 | $0 | 337,500 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-03 5:19 pm |
N/A N/A |
ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO |
233,333 | $0 | 750,000 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:23 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
7,693 | $0 | 49,365 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 8:10 pm |
N/A N/A |
ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-11 4:33 pm |
N/A 2033-10-09 |
ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO |
800,000 | $0 | 800,000 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:40 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
9,792 | $0 | 41,672 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-23 4:44 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
14,035 | $0 | 31,880 (Direct) |
View |
| 2022-04-06 Option Award |
2022-04-08 5:12 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
17,845 | $0 | 17,845 (Direct) |
View |
Ownership |
2022-04-08 5:11 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-11-24 Equity Swap |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
600,000 | $0 | 0 (Direct) |
View |
| 2021-11-24 Option Award |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
75,000 | $0 | 0 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-03 5:01 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer |
300,000 | $0 | 525,000 (Direct) |
View |